Skip to main content
Fig. 4 | Journal for ImmunoTherapy of Cancer

Fig. 4

From: Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis

Fig. 4

Comparisons of the sensitivity and specificity for the prediction of overall, disease-free and distant metastasis-free survival by the combined ICS and TNM stage model, the TNM stage alone model, and the ICS alone model. Receiver operating characteristics (ROC) curves of (a) overall survival, (b) disease-free survival and (c) distant metastasis-free survival in the training cohort and (d) overall survival, (e) disease-free survival and (f) distant metastasis-free survival in the validation cohort. P values show the area under the ROC (AUROC) of the combined ICS and TNM stage model versus AUROCs of the TNM stage alone model or the ICS alone model

Back to article page